Fungal keratitis responsive to moxifloxacin monotherapy

Cornea

Volumn 31, Issue 10, 2012, Pages 1206-1209

  Matoba, Alice Y ^a  

^a CULLEN EYE INSTITUTE   (United States)

Author keywords

fluoroquinolone; fungal keratitis; moxi floxacin

Indexed keywords

CEFTAZIDIME; MOXIFLOXACIN; NATAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; ASPERGILLUS FLAVUS; CANDIDA PARAPSILOSIS; CLINICAL ARTICLE; CURVULARIA; FEMALE; FUNGUS CULTURE; HUMAN; KERATOMYCOSIS; MALE; MEDICAL HISTORY; MONOTHERAPY; PAECILOMYCES; PRIORITY JOURNAL; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; AGED; ANTI-INFECTIVE AGENTS; ASCOMYCOTA; ASPERGILLUS; AZA COMPOUNDS; CANDIDA; CORNEAL ULCER; EYE INFECTIONS, FUNGAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOSES; PAECILOMYCES; QUINOLINES; TREATMENT OUTCOME; VISUAL ACUITY; YOUNG ADULT;

EID: 84866244422     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31823f766c     Document Type: Article

References (15)

1. Forster RK, Rebell G, Wilson LA. Dematiaceous fungal keratitis. Clinical isolates and management. Br J Ophthalmol. 1975;59:372-376.
2. Chodosh J, Miller D, Tu EY, et al. Tobramycin-responsive Fusarium oxysporum keratitis. Can J Ophthalmol. 2000;35:29-30.
3. Khor WB, Aung T, Saw SM, et al. An outbreak of Fusarium keratitis associated with contact lens wear in Singapore. JAMA. 2006;295: 2867-2873. (Pubitemid 43974184)
4. Munir WM, Rosenfeld SI, Udell I, et al. Clinical response of contact lens-associated fungal keratitis to topical fluoroquinolone therapy. Cornea. 2007;26:621-624. (Pubitemid 47164726)
5. Rao SK, Lam PT, Li EY, et al. A case series of contact lens-associated Fusarium keratitis in Hong Kong. Cornea. 2007;26:1205-1209. (Pubitemid 350190912)
6. Van Bambeke F, Michot JM, Van Eldere J, et al. Quinolones in 2005: an update. Clin Microbiol Infect. 2005;11:256-280; (Pubitemid 40443832)
7. Review. Erratum in: Clin Microbiol Infect. 2005;11:513.
8. Fostel JM, Montgomery DA, Shen LL. Characterization of DNA topoisomerase I from Candida albicans as a target for drug discovery. Antimicrob Agents Chemother. 1992;36:2131-2138.
9. Shen LL, Fostel JM. DNA topoisomerase inhibitors as antifungal agents. Adv Pharmacol. 1994;29B:227-244.
10. Ozdek SC, Miller D, Flynn PM, et al. In vitro antifungal activity of the fourth generation fluoroquinolones against Candida isolates from human ocular infections. Ocul Immunol Inflamm. 2006;14:347-351. (Pubitemid 44949893)
11. Day S, Lalitha P, Haug S, et al. Activity of antibiotics against Fusarium and Aspergillus. Br J Ophthalmol. 2009;93:116-119.
12. Stergiopoulou T, Meletiadis J, Sein T, et al. Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus. Antimicrob Agents Chemother. 2008;52:2196-2204. (Pubitemid 351758559)
13. Nakajima R, Kitamura A, Someya K, et al. In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi. Antimicrob Agents Chemother. 1995;39:1517-1521.
14. Petrou MA, Rogers TR. In-vitro activity of antifungal agents in combination with four quinolones. Drugs Exp Clin Res. 1988;14:9-18.
15. Sugar AM, Liu XP, Chen RJ. Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs. Antimicrob Agents Chemother. 1997;41:2518-2521. (Pubitemid 27467566)